The study evaluated the accuracy for predicting pathologic complete response (pCR) after neo-adjuvant systemic therapy (NST) using ultrafast dynamic contrast-enhanced (UF-DCE) MRI. The receiver operating characteristics (ROC) analysis for the presence of residual lesion revealed higher diagnostic performance of UF-DCE MRI compared with conventional dynamic contrast-enhanced (DCE) MRI overall and in the group of triple negative subtype. The deviation from pathology was smaller for UF-DCE MRI derived sizes compared to conventional DCE MRI overall and in luminal group. UF-DCE MRI potentially assesses the post-NAC status in breast cancer patients accurately in a shorter acquisition time.
How to access this content:
For one year after publication, abstracts and videos are only open to registrants of this annual meeting. Registrants should use their existing login information. Non-registrant access can be purchased via the ISMRM E-Library.
After one year, current ISMRM & ISMRT members get free access to both the abstracts and videos. Non-members and non-registrants must purchase access via the ISMRM E-Library.
After two years, the meeting proceedings (abstracts) are opened to the public and require no login information. Videos remain behind password for access by members, registrants and E-Library customers.
Keywords